Buyers widening their own doors: demand already secured, far-side receiving constraint now being cleared
The model's full reasoning — Q2 2023 call → NO我们根据提供的财报电话会议记录,判断管理层是否传达了以下情况:公司已经拥有已确保的业务或需求,但交付量受限于对方(如合作伙伴、客户)自身的接收、安装、认证等能力,且对方正在努力解决这些接收端问题,相关业务大多尚未反映在已报告的结果中。 在电话会议中,管理层讨论了与Janssen的合作协议,该协议已签署并收到首付款,但后续的临床开发、监管和商业化工作仍在进行中。管理层提到“我们正在启动合作”,并说“我们正在与Janssen团队合作,开始将一切付诸行动”,这表明合作正在推进,但尚未产生大量已交付的业务。然而,这里的关键是:业务是否已经“在手”?合作协议本身是已签署的,但临床开发、监管批准和商业化尚未完成,因此业务尚未真正交付。管理层没有明确说“需求已经存在,但受限于对方的接收能力”。相反,他们谈论的是合作启动和未来里程碑。 关于MD Anderson的试验,管理层提到“我们期待在接下来的几周内报告胰腺癌的初步数据”,但这些是临床试验数据,不是已确保的业务。关于NANORAY-312试验,管理层说“我们有望在2024年下半年报告中期疗效”,这也是未来事件。 管理层没有描述任何“对方正在准备接收”的情况,比如合作伙伴正在建设设施、招聘人员等。他们提到Janssen将提供开发支持,但这是合作的一部分,不是接收端约束。 因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| NC | NACCO Industries, Inc. | Q1 2024 | 2024-05-05 | C+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| EXP | Eagle Materials Inc. | Q3 2022 | 2022-01-27 | B |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| BIIB | Biogen Inc. | Q2 2017 | 2017-07-25 | B |
| PDCO | Patterson Companies, Inc. | Q3 2017 | 2017-02-23 | C |
| ARAY | Accuray Incorporated | Q4 2016 | 2016-08-17 | B |
MKC · Q2 2018 → YESThe question is about whether management conveys that they already have secured business or demand, but the bottleneck is the counterparties' ability to receive, install, etc., and those counterpartie...**NO** The transcript describes a situation where McCormick has already won shelf-space changes and distribution improvements from retailers (customers have accepted the recommendations), but implementation is delayed due to retailers' own operational reset windows and competitor product sell-through. This is framed as a temporary, ongoing industry practice rather than a binding constraint being actively cleared right now to unlock a meaningfully larger volume of already-secured business. Management presents it as part of their category-management progress with runway ahead, not as counterparties clearing a receiving-side bottleneck that is already underway and will drive the bulk of the upside.
BIIB · Q2 2017 → YESThe question is about whether management conveys that they already have secured demand, but the bottleneck is the counterparties' ability to receive/install/etc., and those counterparties are already ...YES The transcript shows management conveying exactly this situation for SPINRAZA. Demand is already secured and arriving: “significant uptake in the U.S.” with “strong demand across patient types” and “roughly two third of patients treated to date having Type 2 or Type 3 SMA.” The binding constraint is on 60% of Type 2 patients who have had spinal surgery, creating intrathecal administration challenges on the receiving side.
BXP · Q1 2022 → YESThe question is about whether management conveys that they already have secured business or demand, but the bottleneck is the counterparties' ability to receive/install/etc., and those counterparties ...YES The transcript shows management conveying secured demand through signed leases totaling over 975,000 square feet on vacant space that have not yet commenced occupancy, plus an additional 1.3 million square feet in active negotiations and over 750,000 square feet in the development pipeline.